Last reviewed · How we verify

Ketoprofen in Transfersome — Competitive Intelligence Brief

Ketoprofen in Transfersome (Ketoprofen in Transfersome) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID. Area: Pain Management.

phase 2 NSAID COX-2 Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Ketoprofen in Transfersome (Ketoprofen in Transfersome) — IDEA AG. Inhibits COX-2

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Ketoprofen in Transfersome TARGET Ketoprofen in Transfersome IDEA AG phase 2 NSAID COX-2
Celebrex celecoxib Pfizer Inc. (originally Searle/Pharmacia) marketed Nonsteroidal Anti-inflammatory Drug [EPC] COX-2 1998-12-31
Cytotec Misoprostol Pfizer marketed NSAID combined with prostaglandin analog Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors 1988-01-01
Ropivacaine, Ketorolac and Adrenaline Ropivacaine, Ketorolac and Adrenaline University of Aarhus marketed Local anesthetic combination with NSAID and vasopressor Voltage-gated sodium channels (ropivacaine); COX-1 and COX-2 (ketorolac); alpha and beta adrenergic receptors (adrenaline)
hydrochloride hydromorphone + flurbiprofen axetil hydrochloride hydromorphone + flurbiprofen axetil First Affiliated Hospital, Sun Yat-Sen University marketed Opioid analgesic + NSAID combination Mu-opioid receptor (hydromorphone); COX-1/COX-2 (flurbiprofen axetil)
Cox2 inhibitor (Celecoxib) Cox2 inhibitor (Celecoxib) Seoul National University Hospital marketed COX-2 selective inhibitor (coxib) COX-2 (Cyclooxygenase-2)
ABS ABS Teva Branded Pharmaceutical Products R&D, Inc. marketed Nonsteroidal anti-inflammatory drug (NSAID) COX-1 and COX-2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (NSAID class)

  1. Antibe Therapeutics Inc. · 3 drugs in this class
  2. Iroko Pharmaceuticals, LLC · 3 drugs in this class
  3. Organon and Co · 2 drugs in this class
  4. Apsen Farmaceutica S.A. · 2 drugs in this class
  5. Amneal Pharmaceuticals, LLC · 2 drugs in this class
  6. Behar, Caren, M.D. · 2 drugs in this class
  7. IDEA AG · 2 drugs in this class
  8. Noven Pharmaceuticals, Inc. · 2 drugs in this class
  9. HALEON · 2 drugs in this class
  10. Pfizer · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ketoprofen in Transfersome — Competitive Intelligence Brief. https://druglandscape.com/ci/ketoprofen-in-transfersome. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: